Previous close | 9.05 |
Open | 9.00 |
Bid | 8.58 x 100 |
Ask | 8.90 x 100 |
Day's range | 8.61 - 9.11 |
52-week range | 3.21 - 10.69 |
Volume | |
Avg. volume | 101,137 |
Market cap | 126.601M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Coya Therapeutics...
Key Financial Highlights and Strategic Collaborations Mark COYA's Year-End Summary
Renowned investment firm Greenlight Capital, led by David Einhorn (Trades, Portfolio), has recently expanded its investment portfolio with the acquisition of shares in Coya Therapeutics Inc (NASDAQ:COYA). On December 12, 2023, the firm added 810,959 shares to its holdings, reflecting a significant commitment to the biotechnology company.